Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises in the divestment of Creuna to Knowit
Mandate

Vinge advises in the divestment of Creuna to Knowit

October 22, 2020 M&A

Vinge advises the seller in the divestment of Creuna to Knowit AB (publ). Creuna is a Nordic digital agency with around 300 employees in Denmark, Norway, Sweden and Finland.

The acquisition is conditional upon the approval from the competition authority in Norway, which is expected to be granted during the fourth quarter of 2020.

Vinge’s team consisted of among others Jonas Bergström, Joacim Rydergård, Johanna Wiberg and Karl Klackenberg.

 

 

Related

Vinge advised Precise Biometrics

 Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

 Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026